Table 3.
Point Estimate | Low | High | Source | |
---|---|---|---|---|
CRAB incidence | 43,200 | ECDC | ||
Reduced transmission rate | 40% | Estimated | ||
Cost of treating resistant case | €14,913 | €1,000 | €25,685 | Adapted from SR |
CRAB mortality rate | 20% | SR, ICU estimates | ||
Life-years gained from avoided infection | 12 | SR, ICU estimates | ||
Utility value of quality of life gained from avoided infection | 0.8 | SR, ICU estimates |
CRAB, carbapenem-resistant Acinetobacter baumannii; ECDC, European Centre for Disease Prevention and Control; ICU, intensive care unit; SR, Spellberg and Rex.28